Chi­nese on­col­o­gy play­er is the lat­est to join the North Car­oli­na man­u­fac­tur­ing par­ty with 2 new plants in the off­ing

While Boston and the Bay Area reign supreme in terms of biotech hotspots, oth­er hubs are hav­ing their chance in the sun amid a flur­ry of cash flood­ing the in­dus­try. North Car­oli­na, for in­stance, has seen a ton of com­pa­nies look­ing to es­tab­lish a foot­print in the state — and now a Shang­hai-based on­col­o­gy play­er will join the fold.

CARs­gen Ther­a­peu­tics will open two new sites in Raleigh-Durham, cre­at­ing the com­pa­ny’s first man­u­fac­tur­ing hub that will com­ple­ment its clin­i­cal de­vel­op­ment site in Hous­ton, the com­pa­ny said Mon­day.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.